MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Non-motor Scales"

  • 2019 International Congress

    Cognitive event related potentials as biomarker of non-motor phenotypes in Parkinson’s Disease

    N. Koshel, S. Kryzhanovskyi, N. Karasevych, A. Pisaruk, I. Karaban (Kyiv, Ukraine)

    Objective: This research aimed to study the specific changes in cognitive event related potentials (ERP) in patients with different non-motor subtypes of Parkinson’s disease (PD).…
  • 2019 International Congress

    Comparison between the Movement Disorders Society – Non-Motor Rating Scale (MDS-NMS) and the Non-Motor Symptoms Scale (NMSS)

    A. Schrag, A. Rizos, C. Rodriguez-Blazquez, D. Weintraub, KR. Chaudhuri, P. Martinez-Martin (Madrid, Spain)

    Objective: To compare the performance of the Movement Disorders Society – Non-Motor Rating Scale (MDS-NMS) and its predecessor, the Non-Motor Symptoms Scale (NMSS). Background: The…
  • 2019 International Congress

    Long term evolution of ventilatory function in Parkinson’s disease

    G. Baille, C. Chenivesse, T. Perez, D. Devos, L. Defebvre, C. Moreau (Lille, France)

    Objective: To assess the evolution of lung volumes and respiratory muscle strength after a 5 years follow-up in a cohort of patients with Parkinson’s disease…
  • 2019 International Congress

    Non-motor symptoms in Parkinson disease motor subtypes: a study using the new MDS-NMS

    P. Martinez-Martin, C. Rodriguez-Blazquez, A. Schrag, D. Weintraub, A. Rizos, KR. Chaudhuri (Madrid, Spain)

    Objective: To analyze the prevalence and severity of non-motor symptoms (NMS) in Parkinson disease (PD) motor subtypes (tremor-dominant, TD; postural instability/gait disorder, PIGD; and indeterminate),…
  • 2019 International Congress

    Seeking regulatory feedback on novel clinical outcome assessments: a case example from the Huntington’s Disease – Regulatory Science Consortium (HD-RSC)

    A. Mullin, R. Fuller, G. Stebbins, J. Stout, A. Robbins, P. Feigenbaum, M. Roche, E. Gantman, C. Sampaio, M. Brumfield (Tucson, AZ, USA)

    Objective: To align with regulators on the utility and development strategy of novel clinical outcome assessments for use in Huntington’s disease (HD) clinical trials. Background:…
  • 2019 International Congress

    Drooling in Parkinson’s Disease: A [123I]FP-CIT SPECT study

    V. Suarez Contreras, Y. Tayyabah, S. Caminiti, M. Politis (London, United Kingdom)

    Objective: Evaluate the association between drooling and striatal dopamine terminals. Test the assumption that drooling correlates with disease progression in de novo Parkinson’s disease (PD)…
  • 2019 International Congress

    The influence of physical activities on cognition in small group of Parkinson’s Disease patients

    J. Silva, M. Pereira, L. Piovesara, P. Azevedo, F. Cendes, A. D'Abreu, R. Guimarães (Campinas, Brazil)

    Objective: To assess the relation between cognitive performance and physical exercise in Parkinson's Disease patient. Background: Cognitive deficit is a common non-motor symptom in PD,…
  • 2019 International Congress

    Non motor fluctuations in Parkinson’s disease: Findings from a Tunisian cohort

    M. Ben Djebara, K. Laabidi, A. Nasri, A. Rekik, S. Mrabet, A. Gargouri, I. Kacem, R. Gouider (Tunis, Tunisia)

    Objective: To evaluate the frequency of non motor fluctuations (NMF) in Parkinson's disease (PD), their correlation with motor complications and their impact on the quality…
  • 2019 International Congress

    Relationship between striatal dopamine depletion and various non-motor symptoms in non-demented patients with Parkinson’s disease: a pilot study

    JY. Lee, H. Ju, K. Im, MY. Ahn, KY. Kwon (Seoul, Republic of Korea)

    Objective: We aimed to investigate associations of striatal dopamine uptake and various non-motor symptoms in non-demented patients with Parkinson’s disease (PD). Background: Dopamine transporter (DAT)…
  • 2019 International Congress

    Effect of opicapone in Parkinson’s disease patients with ‘early’ motor fluctuations: Parkinson’s Disease Questionnaire (PDQ-39) analysis from the BIPARK-I double-blind experience

    J. Rocha, E. Tolosa, J. Ferreira, A. Lees, O. Rascol, W. Poewe, A. Santos, D. Magalhães, P. Soares-da-Silva (Coronado, Portugal)

    Objective: To evaluate the impact of opicapone (OPC) on PDQ-39 in levodopa-treated Parkinson’s Disease (PD) patients with ‘early’ motor fluctuations. Background: OPC, a once-daily COMT…
  • « Previous Page
  • 1
  • …
  • 33
  • 34
  • 35
  • 36
  • 37
  • …
  • 55
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • #24970 (not found)
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley